Modeling of Vishay Intertechnology VJ HIFREQ Series MLCCs Now Available From Modelithics®
Mar 18, 2016 15:00 pm UTC| Business
MALVERN, Pa., March 18, 2016 -- To help designers simulate circuit performance and reduce time to market, Vishay Intertechnology, Inc. (NYSE:VSH) today announced that Modelithics®, Inc. — the industry leader in...
Mar 18, 2016 14:45 pm UTC| Business
Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/hmsh4z/industrial) has announced the addition of the "Industrial Semiconductors - Global Strategic Business Report"...
Mar 18, 2016 14:23 pm UTC| Business
Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/wh78nb/biochips_global) has announced the addition of the "Biochips - Global Strategic Business Report" report to...
United States ACO IT Spending Market Report 2016-2020
Mar 18, 2016 14:19 pm UTC| Business
Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/wbl7n7/us_aco_it) has announced the addition of the "US ACO IT Spending Outlook 2020" report to their offering. ...
Shareholder Lawsuit Filed Against Insys Therapeutics: Kessler Topaz Meltzer & Check LLP
Mar 18, 2016 14:02 pm UTC| Business
RADNOR, Pa., March 18, 2016 -- Kessler Topaz Meltzer Check, LLP files shareholder class action lawsuit against Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or the “Company”) on behalf of purchasers of the Company’s...
GTAT Completes Financial Restructuring – Emerges from Chapter 11
Mar 18, 2016 14:02 pm UTC| Business
MERRIMACK, N.H., March 18, 2016 -- GT Advanced Technologies Inc. today announced that it has emerged from Chapter 11 as a newly reorganized company. GT Advanced Technologies Inc. and its affiliated debtors (“GTAT”) have...
ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV) to Ring The Nasdaq Stock Market Closing Bell
Mar 18, 2016 14:00 pm UTC| Business
ADVISORY, March 18, 2016 -- What: ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, will visit the Nasdaq...